Ancobon Related Published Studies
Well-designed clinical trials related to Ancobon (Flucytosine)
Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi. [2010.02.01]
High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. [2008.07.01]
Oral versus intravenous flucytosine in patients with human immunodeficiency virus-associated cryptococcal meningitis. [2007.03]
Oral versus intravenous flucytosine in patients with HIV-associated cryptococcal meningitis. [2006.12.28]
Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine. [1999]
Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS. [1998.06]
Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS. [1997.07]
Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group. [1996.12]
A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients. [1996.11]
Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study. [1995.06]
[A comparative clinical study on flucytosine alone and in combination with fluconazole in hematological malignancies: a multicenter study using the envelope method] [1994.10]
Amphotericin B versus amphotericin B plus 5-flucytosine: poor results in the treatment of proven systemic mycoses in neutropenic patients. [1994.03]
Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses. [1993.11]
Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. [1992.02]
Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. [1990.08.01]
Well-designed clinical trials possibly related to Ancobon (Flucytosine)
Adaptive seamless design for an efficacy trial of replication-competent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP Trial). [2011.05]
Clinical pharmacokinetics of oral controlled-release 5-fluorocytosine. [2010.03]
Poor efficacy of amphotericin B-based therapy in CNS aspergillosis. [2007.05]
A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II. [2006.06]
Combination therapy for invasive mycoses: evaluation of past clinical trial designs. [2004.10.15]
Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis. [2004.06.15]
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. [2004.05.29]
Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. [2000.01]
A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group. [1999.02]
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. [1997.07.03]
Candida albicans arthritis in a nonimmunocompromised patient. Complication of placebo intraarticular injections. [1993.12]
Function of the adrenal cortex during therapy with fluconazole in intensive care patients. [1993.03]
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. [1992.01.09]
Itraconazole in neutropenic patients. [1992]
A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. [1991.02.28]
The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B. [1991.01]
Interventional antimicrobial strategy in febrile neutropenic patients. Results of a multicenter study in 1,260 patients with hematological malignancies. The Interventional Antimicrobial Strategy Study Group, Paul Ehrlich Society for Chemotherapy. [1990.02]
Other research related to Ancobon (Flucytosine)
Comparison of the Early Fungicidal Activity of High-Dose Fluconazole, Voriconazole, and Flucytosine as Second-Line Drugs Given in Combination With Amphotericin B for the Treatment of HIV-Associated Cryptococcal Meningitis. [2011.11.03]
Treatment of severe chromoblastomycosis with itraconazole and 5-flucytosine association. [2010.12]
Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient. [2010.03]
[Evaluation of low-dose amphotericin B and flucytosine in the treatment of cryptococcal meningitis] [2010.02.09]
Combination flucytosine and high-dose fluconazole compared with fluconazole
monotherapy for the treatment of cryptococcal meningitis: a randomized trial in
Malawi. [2010]
Successful treatment of Cryptococcal meningitis with a combination of liposomal amphotericin B, flucytosine and posaconazole: two case reports. [2009.05]
In vitro activities at pH 5.0 and pH 7.0 and in vivo efficacy of flucytosine against Aspergillus fumigatus. [2008.12]
Major role for amphotericin B-flucytosine combination in severe cryptococcosis. [2008.08.06]
Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis. [2008.06]
Treatment of fungal peritonitis with a combination of intravenous amphotericin B and oral flucytosine, and delayed catheter replacement in continuous ambulatory peritoneal dialysis. [2008.03]
Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp. [2007.11]
Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosing. [2007.10]
Serum and intraperitoneal levels of amphotericin B and flucytosine during intravenous treatment of critically ill patients with Candida peritonitis. [2007.05]
Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory. [2006.12]
Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis. [2006.01]
Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata. [2005.11]
Efficacy and pharmacodynamics of flucytosine monotherapy in a nonneutropenic murine model of invasive aspergillosis. [2005.10]
A case of chromoblastomycosis with an unusual clinical manifestation caused by Phialophora verrucosa on an unexposed area: treatment with a combination of amphotericin B and 5-flucytosine. [2005.03]
Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. [2003.11]
Fluconazole in combination with flucytosine in the treatment of fluconazole-resistant Candida infections. [2003.07]
An in vitro study on the active conversion of flucytosine to fluorouracil by microorganisms in the human intestinal microflora. [2003.05]
Flucytosine and cryptococcosis: which in vitro test is the best predictor of outcome? [2003.04]
A flucytosine-resistant Cryptococcus neoformans (serotype D) strain isolated in turkey from cutaneous lesions. [2002.10]
Successful treatment of cryptococcal osteomyelitis and paraspinous abscess with fluconazole and flucytosine. [2001.09]
Combined topical flucytosine and amphotericin B for refractory vaginal Candida glabrata infections. [2001.06]
Interactions of posaconazole and flucytosine against Cryptococcus neoformans. [2001.05]
Prediction of flucytosine-induced thrombocytopenia using creatinine clearance. [2000.09]
Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. [2000.08]
In vivo characterization of the pharmacodynamics of flucytosine in a neutropenic murine disseminated candidiasis model. [2000.04]
Flucytosine: correlation between toxicity and pharmacokinetic parameters. [2000.03]
Gene therapy for human hepatocellular carcinoma with cytosine deaminase gene and prodrug flucytosine. [1999.05]
Antifungal agents. Part I. Amphotericin B preparations and flucytosine. [1998.12]
Flucytosine monotherapy for cryptococcosis. [1998.08]
Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis. [1998.03]
Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen. [1998]
Combination therapy with fluconazole and flucytosine for pulmonary cryptococcosis. [1997.11]
Efficacy of a short-term amphotericin B + flucytosine combination therapy followed by itraconazole monotherapy in acute and chronic AIDS-associated cryptococcosis. [1997.10]
Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis. [1997.07]
Atypical eumycetoma caused by Phialophora parasitica successfully treated with itraconazole and flucytosine. [1997.06]
Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis. [1997.05]
Acute cerebellopathy as a probable toxic effect of flucytosine. [1997]
Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS. [1996.12]
Efficacy of continuous flucytosine infusion against Candida lusitaniae in experimental hematogenous murine candidiasis. [1996.12]
Suspected drug eruption in seven dogs during administration of flucytosine. [1996.10]
Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitis. [1996.09]
Clinical efficacy of itraconazole with initial flucytosine in AIDS-related cryptococcal meningitis: a preliminary study. [1996.07]
Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome. [1996.05]
Itraconazole and flucytosine+itraconazole combination in the treatment of experimental cryptococcosis in hamsters. [1995.11]
Structural determination of a glucuronide conjugate of flucytosine in humans. [1995.08]
[Study of serial bronchoalveolar lavage in patients with aspergilloma: cell reaction at the affected sites and penetration of miconazole and flucytosine into the lesion] [1995.05]
Comparison of fluconazole, amphotericin B and flucytosine in treatment of a murine model of disseminated infection with Candida glabrata in immunocompromised mice. [1995.05]
Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice. [1995.04]
Flucytosine dosing in an obese patient with extrameningeal cryptococcal infection. [1995.03]
Flucytosine+fluconazole association in the treatment of a murine experimental model of cryptococcosis. [1994.11]
Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. [1994.10]
Rhodotorula spp. fungemia in an immunocompromised boy after neurosurgery successfully treated with miconazole and 5-flucytosine: case report and review of the literature. [1994.07]
Treatment of cryptococcal meningitis with combination itraconazole and flucytosine. [1994.05]
[Pulmonary cryptococcosis treated by combination therapy of fluconazole plus flucytosine] [1993.12]
Treatment of Candida arthritis with flucytosine and amphotericin B. [1993.09]
[Candida meningitis, in a premature infant, treated with liposomal amphotericin B and flucytosine] [1993.03]
Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy. [1992.12]
Successful treatment of a Candida albicans sepsis with a combination of flucytosine and fluconazole. [1992.11]
[Clinical evaluation of flucytosine in patients with urinary fungal infections] [1992.08]
Flucytosine conversion to fluorouracil in humans: does a correlation with gut flora status exist? A report of two cases using fluorine-19 magnetic resonance spectroscopy. [1991.05]
Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis. [1991.04]
[Flucytosine in the treatment of urinary fungal infections. Clinical efficacy and background factors] [1991.01]
[Comparative study of the therapy of Candida esophagitis in HIV-1-infected patients with fluconazole or amphotericin B and flucytosine] [1991]
Malabsorption of flucytosine in a pediatric patient with Shwachman syndrome. [1989.10]
Granulocytopenia and thrombocytopenia associated with combination therapy of amphotericin B and low-dose flucytosine in a patient with cryptococcal meningitis. [1989.09]
|
